Effects of environmental thyroid hormone disrupting compounds on CNS development
环境甲状腺激素干扰化合物对中枢神经系统发育的影响
基本信息
- 批准号:9383076
- 负责人:
- 金额:$ 24.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-11-15 至 2019-10-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgonistAnimalsAwardBehaviorBehavioralBiological ModelsBiophysicsBloodBrainCalciumCell DeathCell ProliferationCharacteristicsChemosensitizationCommunicationComplementDataDevelopmentElectrophysiology (science)ElectroporationEndocrine DisruptorsEndocrine PhysiologyEndocrine disruptionEnhancersEnrollmentEnvironmentEnvironmental PollutionEquipmentExposure toEyeFacultyFlame RetardantsFundingGene ExpressionGene Expression RegulationGoalsHandHormone AntagonistsHormonesHumanImageIndustrial ProductInjectableInstitutionKnowledgeLaboratoriesLeadLearningMammalsMeasurableMeasuresMentorsMethimazoleMichiganMicrospheresMilkModelingMolecularMorphologyMusNeuroendocrinologyNeuronal PlasticityNeuronsNeurosciencesPhasePhotonsPlasticizersPlasticsPlayPostdoctoral FellowProductionPropertyPublicationsReceptor ActivationResearchResearch InstituteResearch PersonnelResearch Project GrantsRestRetinaRetinal Ganglion CellsRoleScientistSignal TransductionSiteStructureSupervisionSystemSystems DevelopmentTRPA1 ChannelTadpolesTechnical ExpertiseTechniquesTectum MesencephaliTestingThyroid Hormone ReceptorThyroid HormonesThyroxineTimeTissuesToxic Environmental SubstancesTrainingTranscriptional RegulationTriiodothyronineUniversitiesVertebratesVisualVisual system structureWritingXenopusXenopus laevisconsumer productenvironmental toxicologyexperimental studyhormone metabolismimprovedin vivointerdisciplinary approachliteracymembernerve stem cellneural circuitneurogenesisneuron developmentneurotoxicpostsynapticpublic health relevancereconstructionresponseretinotectalskillsskills trainingsuperior colliculus Corpora quadrigeminatetrabromobisphenol Atwo-photonvision development
项目摘要
DESCRIPTION (provided by applicant)
The candidate's long term goal is to become an independent investigator at an academic research institution to study the effects of hormones and endocrine disrupting compounds on the development and activity of brain circuits. He has received excellent training in neuroendocrinology, neuroplasticity, and behavioral neuroscience. He now plans to complement this knowledge and technical expertise with training in in vivo analysis of the role of endocrine disruptors on neuronal structural plasticity and brain circuit connectivity using targeted manipulation of gene expression via electroporation, time-lapse 2-photon imaging, neuronal reconstruction and structural analysis, electrophysiology and quantification of thyroid hormone levels. During this training period the candidate will enroll in courses and seminars to improve his management abilities, communication skills and technical literacy. By the end of this award, he will have gained the skills and training that will be needed for establishing his own lab. He wil also have the publication record and preliminary data on hand to write a R01 proposal with a high likelihood of funding.
Most of the training during the mentored phase will occur at The Scripps Research Institute (TSRI) under the supervision of Dr. Hollis Cline. Dr. Cline has taken a multidisciplinary approach to studying molecular and cellular mechanisms that govern the development of the visual system in Xenopus laevis tadpoles, including in vivo time-lapse 2 photon imaging, in vivo electrophysiological recordings of visual responses, calcium-imaging and behavior. Her laboratory has been at the forefront of developing exciting new techniques to study the factors that regulate circuit development. Her laboratory is located in the Dorris Neuroscience Center, which is an outstanding intellectual environment consisting of 14 faculty members and more than 100 postdocs and other scientists. Some of the candidate's proposed experiments will benefit from training from a co-mentor, Dr. Ardem Patapoutian, a TSRI faculty member with expertise in biophysics of the TRPA1 channels, which the candidate will use to manipulate neuronal activity. In addition, the candidate will learn techniques to measure thyroid hormone levels in the laboratory of Dr. Robert Denver at the University of Michigan at Ann Arbor. Dr. Denver is a leading expert in endocrine disruption and physiology and will be an invaluable co-mentor to this project.
The goal of this research project is determine the effects of endocrine-disrupting compounds on brain development. Compounds that are used in the production of industrial and consumer products can accumulate in the environment and even be found in human blood and tissue in measurable quantities. There is increasing evidence that some of these compounds can affect hormone metabolism and action, including thyroid hormone, which plays an important role in brain development. Yet little is known about how environmental toxins that disrupt thyroid hormone function affect development of brain circuits. The candidate will determine the effects of thyroid hormone disrupting compounds on CNS development, using the visual system in Xenopus laevis tadpoles, an ideal experimental system for these studies because the external development of the animal provides easy access to the developing brains for observation and manipulation. The candidate will treat tadpoles with the active thyroid hormone triiodothyronine, methimazole (a thyroid hormone antagonist), and several thyroid hormone disrupting compounds. I will assess several parameters of brain development, including neural stem cell proliferation, differentiation and survival, and the development of neuronal structure and circuit connectivity. In addition, he will develop and characterize the use of microspheres as a local thyroid hormone delivery system and use this system to target particular hormone treatments to the retina or the optic tectum. These experiments will allow him to disambiguate the site of hormone action within the developing brain and to localize the sites of action and effects of thyroid hormone disrupting compounds on brain development. These will be important advances in the fields of environmental toxicology, neuroendocrinology and brain development. Furthermore, these experiments will establish the Xenopus retino-tectal system as an ideal model to screen thyroid hormone disrupting compounds for effects on brain development.
描述(由申请人提供)
候选人的长期目标是成为学术研究机构的独立调查员,研究激素和内分泌干扰化合物对大脑回路发育和活动的影响。他在神经内分泌学、神经可塑性和行为神经科学方面接受过出色的培训。他现在计划补充这方面的知识和技术专长的培训,在体内分析的作用,内分泌干扰物对神经元结构可塑性和脑回路连接使用有针对性的操纵基因表达通过电穿孔,延时2光子成像,神经元重建和结构分析,电生理学和甲状腺激素水平的量化。 在此培训期间,候选人将参加课程和研讨会,以提高他的管理能力、沟通能力和技术素养。 在这个奖项结束时,他将获得建立自己的实验室所需的技能和培训。他还将拥有出版记录和手头的初步数据,以编写一份有很高资金可能性的R01提案。
指导阶段的大部分培训将在Hollis Cline博士的监督下在Scripps研究所(TSRI)进行。克莱恩博士采取了多学科的方法来研究控制非洲爪蟾蝌蚪视觉系统发育的分子和细胞机制,包括体内延时2光子成像,视觉反应的体内电生理记录,钙成像和行为。她的实验室一直处于开发令人兴奋的新技术的前沿,以研究调节电路发展的因素。她的实验室位于Dorris神经科学中心,这是一个杰出的智力环境,由14名教职员工和100多名博士后和其他科学家组成。候选人提出的一些实验将受益于共同导师Ardem Patapoutian博士的培训,他是TSRI的教员,具有TRPA 1通道生物物理学方面的专业知识,候选人将使用该通道来操纵神经元活动。 此外,候选人将在密歇根大学安阿伯分校罗伯特·丹佛博士的实验室学习测量甲状腺激素水平的技术。Denver博士是内分泌干扰和生理学方面的领先专家,将成为该项目的宝贵共同导师。
该研究项目的目标是确定内分泌干扰化合物对大脑发育的影响。用于工业和消费品生产的化合物可以在环境中积累,甚至可以在人体血液和组织中以可测量的数量发现。越来越多的证据表明,这些化合物中的一些可以影响激素的代谢和作用,包括甲状腺激素,它在大脑发育中起着重要作用。然而,人们对破坏甲状腺激素功能的环境毒素如何影响大脑回路的发育知之甚少。 候选人将确定甲状腺激素干扰化合物对CNS发育的影响,使用非洲爪蟾蝌蚪的视觉系统,这是这些研究的理想实验系统,因为动物的外部发育提供了观察和操作发育中大脑的方便途径。 候选人将用活性甲状腺激素三碘甲腺原氨酸、甲巯咪唑(一种甲状腺激素拮抗剂)和几种甲状腺激素干扰化合物治疗蝌蚪。我将评估大脑发育的几个参数,包括神经干细胞增殖,分化和存活,以及神经元结构和电路连接的发展。此外,他将开发和表征微球作为局部甲状腺激素递送系统的使用,并使用该系统将特定的激素治疗靶向视网膜或视顶盖。这些实验将使他能够消除发育中的大脑中激素作用的位置,并定位甲状腺激素干扰化合物对大脑发育的作用和影响。这些将是环境毒理学、神经内分泌学和大脑发育领域的重要进展。此外,这些实验将建立爪蟾视网膜顶盖系统作为一个理想的模型,筛选甲状腺激素干扰化合物对大脑发育的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christopher Kirk Thompson其他文献
Christopher Kirk Thompson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christopher Kirk Thompson', 18)}}的其他基金
Effects of environmental thyroid hormone disrupting compounds on CNS development
环境甲状腺激素干扰化合物对中枢神经系统发育的影响
- 批准号:
8712487 - 财政年份:2013
- 资助金额:
$ 24.9万 - 项目类别:
Effects of environmental thyroid hormone disrupting compounds on CNS development
环境甲状腺激素干扰化合物对中枢神经系统发育的影响
- 批准号:
8568570 - 财政年份:2013
- 资助金额:
$ 24.9万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)